Douglas Stine is a notable inventor based in Overland Park, Kansas, who has made significant contributions to the field of veterinary diagnostics. His work primarily focuses on the development of innovative assays that enhance the detection of specific antibodies in animal serum.

Latest Patents

Stine holds a patent for an Enzyme-Linked Immunosorbent Assay (ELISA) designed for the detection of anti-mycoplasma hyorhinis IgG in swine serum. This patent presents a method for selectively identifying anti-IgG in porcine serum, which may contain antibodies specific to multiple other species. His invention plays a crucial role in improving the health management of swine by enabling accurate diagnosis of infections.

Career Highlights

Douglas Stine is currently employed at Boehringer Ingelheim Animal Health USA Inc., where he continues to work on advancing veterinary diagnostic technologies. His expertise in immunoassays has positioned him as a valuable asset in the field of animal health.

Collaborations

Throughout his career, Stine has collaborated with notable colleagues, including Russell F. Bey and Mike Stoll. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Douglas Stine's contributions to veterinary diagnostics through his patented inventions demonstrate his commitment to improving animal health. His work continues to impact the industry positively, ensuring better health outcomes for livestock.

Profile summary based on public USPTO records.